Loading the company…
Loading the company…
Privately held: no public financials. No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 12 decisions for FX Shoulder Solutions (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2020 (4). The latest was on 2024-05-15.
| Lateralized and Augmented Baseplates |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to FX Shoulder Solutions.